from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0172/mce1D

LFCtreatmentdescriptionclass of inhibitor

-1.424

Amikacinug/mL Amikacintranslation

-2.102

Cap5-10ug/mL Capreomycintranslation

-1.924

Rox10-50 ug/mL Roxithromycintranslation

-1.531

SM2-5 ug/mL Streptomycintranslation

-2.523

Tet5-10 ug/mL Tetracyclinetranslation

-0.476

Rif0.2-5ug/mL Rifampicintranscription

0.105

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.214

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.775

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.728

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.979

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.548

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.458

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.040

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.154

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.207

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.583

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.488

KCN5-20 ug/mL Potassium cyaniderespiration

0.272

NaN30.2-2 mM Sodium aziderespiration

-0.547

Nigericin50 uM Nigericinrespiration

-0.968

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.100

Valinomycin0.5-10 uM Valinomycinrespiration

0.470

ZnSO42 mM ZnSO4respiration

0.022

menadione6-10 ug/mL Menadionerespiration

-0.716

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.899

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.210

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.044

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.325

NRP_1Non-replicating persistence stage 1dosRassociated

0.702

Amp0.2mg/mL AmpicillincellWall

0.648

Cephalexin20-100 ug/mL CephalexincellWall

-0.012

Cerulenin0.32-5 ug/mL CerulenincellWall

0.784

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.006

EMB10-20 ug/mL EthambutolcellWall

-0.563

Eta12-40 ug/mL EthionamidecellWall

-0.499

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.538

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.744

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.506

BZA0.12 mg/mL BenzamidearomaticAmides

0.736

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.581

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.499

H2O24 mM hydrogen peroxideDNAdamaging

-0.125

Levo10 ug/mL LevofloxacinDNAdamaging

0.470

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.021

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.404

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.898

Antimycin12.5-50 ug/mL Antimycin A?

-0.493

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.634

PA_110-50 ug/mL Antitubercular compound PA-1?

1.022

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.486

PA8240.2-2 ug/mL PA-824?

-2.762

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.312

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.423

Verapamil50 uM Verapamil?

-0.936

mercaptoethanol2 mM 2-Mercaptoethanol?

0.257

methoxatin10-20 ug/mL Methoxatin?